---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T14:11:48.760103'
end_time: '2025-12-27T14:19:17.307639'
duration_seconds: 448.55
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: RAB15
  gene_symbol: RAB15
  uniprot_accession: P59190
  protein_description: 'RecName: Full=Ras-related protein Rab-15; EC=3.6.5.2 {ECO:0000250|UniProtKB:P61026};'
  gene_info: Name=RAB15 {ECO:0000312|HGNC:HGNC:20150};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the small GTPase superfamily. Rab family.
  protein_domains: P-loop_NTPase. (IPR027417); Rab15. (IPR041826); Small_GTP-bd. (IPR005225);
    Small_GTPase. (IPR001806); Small_GTPase_Rab. (IPR050305)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 24
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P59190
- **Protein Description:** RecName: Full=Ras-related protein Rab-15; EC=3.6.5.2 {ECO:0000250|UniProtKB:P61026};
- **Gene Information:** Name=RAB15 {ECO:0000312|HGNC:HGNC:20150};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Rab15. (IPR041826); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Small_GTPase_Rab. (IPR050305)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB15" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB15' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB15** (gene ID: RAB15, UniProt: P59190) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** P59190
- **Protein Description:** RecName: Full=Ras-related protein Rab-15; EC=3.6.5.2 {ECO:0000250|UniProtKB:P61026};
- **Gene Information:** Name=RAB15 {ECO:0000312|HGNC:HGNC:20150};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Rab15. (IPR041826); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Small_GTPase_Rab. (IPR050305)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB15" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB15' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB15** (gene ID: RAB15, UniProt: P59190) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: Human RAB15 (UniProt P59190)

Plan (concise)
- Verify identity and family: human RAB15, small GTPase, Rab family, P‑loop NTPase. (Verified; see below.)
- Synthesize mechanistic function, localization, interactors, and pathway context from authoritative primary and review literature.
- Prioritize recent developments (2023–2024) for disease associations/applications; integrate earlier mechanistic work for precision.
- Provide quantitative data where available; include URLs and publication dates.

1) Key concepts and definitions
- Identity and family: RAB15 is a human small GTPase of the Rab family that regulates membrane trafficking steps in endocytosis and recycling. Like other Rabs, it cycles between GDP- and GTP-bound states via conserved switch I/II regions and is membrane-anchored by C‑terminal geranylgeranyl prenylation. This matches the UniProt description (small GTPase, P‑loop NTPase; Rab family) and organism (Homo sapiens) (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4).
- Subcellular localization: RAB15 localizes to sorting/early endosomes (SEs/EEs) and the perinuclear endocytic recycling compartment (ERC), where it co-resides with Rab4/5 on SEs and Rab11 on ERC. In polarized contexts, RAB15 has also been associated with apical recycling routes (ARE) (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 4-5, bhuin2014rabproteinsthe pages 3-4). Reviews of endocytic Rab compartmentalization place RAB15 in EE/RE domains (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x) (agola2011rabgtpasesas pages 2-3).
- Primary cargo/process: RAB15 regulates endocytic sorting and recycling of the transferrin receptor (TfR), helping partition cargo between rapid recycling from SEs and slower recycling via the ERC (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).

2) Recent developments and latest research (prioritize 2023–2024)
- Cancer multi-omics signatures: In a 2024 colon cancer study constructing an LLPS-related risk score (LRRS) across TCGA/GEO cohorts, RAB15 was among model genes upregulated in tumors and contributing to a prognostic signature associated with immune features and poor outcomes. While mechanistic roles were not dissected for RAB15, its inclusion highlights contemporary disease relevance (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613) (wang2024anovelliquidliquid pages 13-16).
- Hypopharyngeal cancer theranostics: A 2022 functional-theranostic study tested candidate biomarkers for docetaxel/cisplatin/5-FU response. RAB15 overexpression increased drug resistance in one transfectant clone but not another, indicating inconsistent functional linkage; nonetheless, RAB15 was evaluated as a potential exploratory biomarker (Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (kawatashimamura2022biomarkerdiscoveryfor pages 7-10).
- Neuronal trafficking frameworks: Contemporary reviews continue to place Rab proteins (including RAB15) in neuronal endosomal sorting and polarity, with inhibitory effects on endocytosis and potential negative regulation of recycling discussed in the context of RUFY/RUN-domain effectors (2013 review; Mar 2013, Int J Mol Sci; https://doi.org/10.3390/ijms14036487) (kitagishi2013rufyraband pages 7-9).

3) Mechanism, cellular role, localization, and pathway context
- Biochemical activity and cycle: RAB15 conforms to Rab GTPase biochemistry—GDP/GTP cycling through GEFs and GAPs, membrane association via C‑terminal dual geranylgeranyl groups, and effector binding in the GTP state. The general Rab paradigm and RAB15’s placement within it are well established (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4). Mss4 has been reported to modulate RAB15’s inhibitory effect on TfR trafficking in earlier work referenced alongside REP15 discovery (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 2-3).
- Subcellular localization and domains in the endocytic system: Imaging and biochemical fractionation show RAB15 on SEs and ERC. Its effector REP15 predominantly localizes to the Rab11-positive ERC, not SEs (co-IP with Rab11 and TfR; no association with EEA1), consistent with a role in ERC-mediated recycling (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6).
- Effector specificity—REP15: REP15 was identified as a direct, specific RAB15 effector that prefers RAB15-GTP, colocalizes perinuclearly with RAB15, and regulates TfR recycling. Two-hybrid assays detected strong interaction with RAB15 WT/Q67L but not T22N/N121I; REP15 did not bind Rab11 mutants in similar assays, despite ERC colocalization (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).
- Functional impact on cargo flow: Overexpression of REP15 causes accumulation of internalized TfR and decreased surface TfR without altering TfR internalization kinetics, indicating a selective defect in ERC-to-plasma membrane recycling. Fast recycling from SEs remains intact, consistent with REP15 acting at the ERC branch controlled by RAB15 (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Role within Rab5/Rab4/Rab11 axes: RAB15 is assigned roles in both fast (with Rab4) and slow (with Rab11) recycling circuits emanating from the EE/SE decision point, and may counteract Rab5-driven stimulation of endocytosis. This positions RAB15 as a modulator of sorting at the EE and output via ERC (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x; Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 4-5).
- Related recycling machinery and complexes: Endocytic recycling involves EHD/MICAL-L1–decorated tubular membranes and multiple Rab effectors. While MICAL-L1/EHD1 regulate transferrin and integrin recycling and share interaction paradigms with Rab effectors, REP15 is the RAB15-specific effector documented to control ERC-mediated recycling. Reports also note RAB15 involvement in apical recycling in polarized epithelial systems (Aug 2010, World J Biol Chem; https://doi.org/10.4331/wjbc.v1.i8.254; Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (rahajeng2010importantrelationshipsbetween pages 4-6, bhuin2014rabproteinsthe pages 3-4).

4) Expert opinions and analysis from authoritative sources
- Endosomal domain model: Rab GTPases create mosaic domains that sort cargo and confer directionality via effector networks. Authoritative reviews place RAB15 among EEs/REs, emphasizing its role at the sorting/recycling interface and listing it in both fast and slow recycling circuits—a relatively uncommon dual placement that underscores context-specific engagement (Nov 2011, Clinical Genetics; https://doi.org/10.1111/j.1399-0004.2011.01724.x) (agola2011rabgtpasesas pages 2-3).
- Inhibitory role in endocytosis: Reviews summarize that RAB15 overexpression inhibits fluid-phase and receptor-mediated endocytosis and in vitro inhibits homotypic EE fusion, suggesting an antagonistic relationship with Rab5-driven entry, while selectively affecting recycling from early compartments depending on mutant state (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 4-5).

5) Relevant statistics and data from recent/primary studies
- Co-localization metrics (confocal microscopy): REP15 colocalizes with RAB15 WT 63 ± 3.4% and with RAB15-Q67L 70 ± 4.4% (perinuclear enrichment). REP15 overlaps with endogenous Rab11 56 ± 7.1% in the ERC; no significant overlap with EEA1 or Rab4 (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6).
- Transferrin traffic dynamics: Following a 1-min chase, Alexa‑Tf colocalizes 57.9 ± 13.6% with EEA1 (SEs), 11.1 ± 3.0% with Rab11, and 23.8 ± 3.8% with REP15; after a 30‑min chase, Rab11 68.1 ± 4.3% and REP15 54.4 ± 1.8%, consistent with ERC arrival (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Internalization kinetics (biotinylation assays): TfR internalization rate constants Ke were similar with or without REP15 overexpression (0.2630 ± 0.035 min⁻¹ vs 0.2435 ± 0.052 min⁻¹), indicating REP15’s effect is on recycling rather than internalization (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- Fast vs slow recycling specificity: REP15 overexpression reduced ERC-derived recycling but left rapid SE-mediated recycling unchanged, reinforcing RAB15–REP15 specificity for the ERC branch (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 6-8).
- 2024 cancer signature (LRRS): The Frontiers in Immunology study reports an LLPS-related 14‑gene signature that includes RAB15, upregulated in tumors and associated with immune and prognostic differences across colon cancer cohorts (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613) (wang2024anovelliquidliquid pages 13-16).
- 2022 hypopharyngeal cancer theranostics: RAB15 overexpression increased docetaxel and cisplatin resistance in one clone but not another in BICR6 cells; no consistent correlation was validated across all transfectants, cautioning interpretation (Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

6) Current applications and real-world implementations
- Biomarker exploration: RAB15 has been evaluated as a component of prognostic/molecular signatures (e.g., LLPS-related risk scores in colon cancer) and as an exploratory biomarker in drug-response prediction for hypopharyngeal cancer. These applications are early-stage and largely computational/experimental; clinical utility remains to be validated (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613; Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).
- Mechanistic experimental systems: RAB15–REP15 tools (mutants, overexpression/siRNA) are used to dissect EE/SE versus ERC recycling of TfR in human cell lines, providing a reference system for endocytic pathway perturbation (Dec 2005, Mol Biol Cell; https://doi.org/10.1091/mbc.E05-03-0204) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8).

7) Disease/physiology links and expert analysis
- Neuronal biology: Endosomal recycling and Rab networks are central to neuronal polarity and synaptic function. RAB15 is discussed as inhibitory for endocytosis and potentially a negative regulator of recycling in neuronal contexts, although direct RAB15-focused neuronal in vivo data remain limited relative to other Rabs (Mar 2013, Int J Mol Sci; https://doi.org/10.3390/ijms14036487) (kitagishi2013rufyraband pages 7-9).
- Epithelial polarity and apical recycling: Reviews enumerate RAB15 among Rabs implicated in apical recycling/transcytosis, consistent with its ERC/ARE distribution and role in routing cargo to the plasma membrane (Oct 2014, Experimental Cell Research; https://doi.org/10.1016/j.yexcr.2014.07.027) (bhuin2014rabproteinsthe pages 3-4, bhuin2014rabproteinsthe pages 4-5).
- Oncology: Contemporary signatures implicate RAB15 expression changes in tumor biology; mechanistic oncogenic roles for RAB15 per se are not established, and functional data are mixed in cell-based drug response assays, suggesting any biomarker role should be validated in disease-relevant systems (Dec 2024, Frontiers in Immunology; https://doi.org/10.3389/fimmu.2024.1514613; Jul 2022, BMC Cancer; https://doi.org/10.1186/s12885-022-09853-1) (wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

Key artifact (concise fact table)
| Aspect | Evidence-based summary (with context IDs) | Quantitative data (numeric values where available, with context IDs) | Representative sources |
|---|---|---:|---|
| Identity / Family | Small GTPase, Rab family; human RAB15 (UniProt P59190) implicated in endocytic trafficking and recycling (bhuin2014rabproteinsthe pages 3-4, agola2011rabgtpasesas pages 2-3). | — | Bhuin & Roy 2014; Agola et al. 2011 |
| Biochemical activity (GTPase cycle; interaction with Mss4) | Functions as a canonical Rab: cycles GDP/GTP, membrane-associated via prenylation; Mss4 reported to modulate Rab15's inhibitory effect on TfR trafficking (bhuin2014rabproteinsthe pages 3-4, strick2005rab15effectorprotein pages 2-3). | — | Bhuin & Roy 2014; Strick & Elferink 2005 |
| Subcellular localization | Localizes to sorting/early endosomes (SEs) and perinuclear endocytic recycling compartment (ERC); also reported in apical/ARE contexts in polarized cells (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 3-4). | — | Agola et al. 2011; Bhuin & Roy 2014; Rahajeng et al. 2010 |
| Effectors (REP15 specificity and Rab15-GTP binding) | REP15 identified as a Rab15-specific effector that preferentially binds GTP-bound Rab15 and colocalizes on ERC membranes; REP15 does not bind Rab5 or Rab11 in two-hybrid/binding assays (strick2005rab15effectorprotein pages 1-2, strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6). | Binding specificity: REP15 binds Rab15-GTP (strong) and shows little/no binding to Rab5 or Rab11 in assays (strick2005rab15effectorprotein pages 2-3, strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Cargo regulated (example) | Transferrin receptor (TfR) trafficking is a well-characterized cargo: Rab15 and its effector REP15 regulate sorting between SEs and ERC and recycling to plasma membrane (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | Altered TfR accumulation in REP15-overexpressing cells (see kinetics below) (strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Functional role in recycling | Rab15 modulates endocytic sorting and both fast and slow recycling routes; overexpression/inactive mutants differentially alter TfR trafficking—Rab15 can inhibit endocytic internalization and affect ERC-derived (slower) recycling (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3, strick2005rab15effectorprotein pages 4-6). | REP15 overexpression → accumulation of internalized TfR (peak later than control), indicating inhibited ERC→plasma membrane recycling (strick2005rab15effectorprotein pages 4-6). | Bhuin & Roy 2014; Agola et al. 2011; Strick & Elferink 2005 |
| Interplay with Rab5 / Rab4 / Rab11 axes | Rab15 occupies SE/RE domains alongside Rab5, Rab4 and Rab11 and is described as part of both fast (Rab4/Rab15) and slow (Rab11/Rab15) recycling circuits; may counteract Rab5-driven stimulation of endocytosis (bhuin2014rabproteinsthe pages 4-5, agola2011rabgtpasesas pages 2-3). | — | Agola et al. 2011; Bhuin & Roy 2014 |
| Representative co-localization metrics | REP15 colocalization with Rab15 and Rab11 and Alexa-Tfn dynamics through SE→ERC are quantified in cell imaging experiments (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | REP15 colocalized with WT Rab15: 63 ± 3.4% and with Rab15-Q67L: 70 ± 4.4%; cMyc-REP15 with Rab15 (perinuclear): 54 ± 5.2% and 56 ± 4.4%; cMyc-REP15 overlap with Rab11: 56 ± 7.1% (strick2005rab15effectorprotein pages 4-6). Alexa-Tfn colocalization: at 1-min chase EEA1 57.9 ± 13.6%; Rab11 11.1 ± 3.0%; REP15 23.8 ± 3.8%; at 30-min chase Rab11 68.1 ± 4.3% and REP15 54.4 ± 1.8% (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8). | Strick & Elferink 2005 |
| Internalization vs recycling kinetics | Surface biotinylation/internalization assays measured internalization and recycling rate constants; REP15 overexpression changes recycling dynamics consistent with ERC retention (strick2005rab15effectorprotein pages 4-6). | Internalization rate constants (Ke): REP15-overexpressing cells Ke = 0.2630 ± 0.035 min⁻¹ vs control Ke = 0.2435 ± 0.052 min⁻¹ (strick2005rab15effectorprotein pages 4-6). | Strick & Elferink 2005 |
| Disease / physiology associations (2022–2024) | Reports link RAB15 expression to cancer signatures and biomarker studies with inconsistent functional effects on drug sensitivity; roles proposed in neuronal polarity/trafficking and reproductive proteomics signatures (kawatashimamura2022biomarkerdiscoveryfor pages 7-10, wang2024anovelliquidliquid pages 13-16, rahajeng2010importantrelationshipsbetween pages 4-6). | Kawata-Shimamura et al. 2022: RAB15 overexpression increased resistance in some transfectants but results were inconsistent across variants; Wang et al. 2024: RAB15 upregulated in an LLPS-related colon cancer signature (kawatashimamura2022biomarkerdiscoveryfor pages 7-10, wang2024anovelliquidliquid pages 13-16). | Kawata-Shimamura et al. 2022; Wang et al. 2024; Rahajeng et al. 2010 |


*Table: Concise, evidence-linked summary of human RAB15 (UniProt P59190) covering identity, activity, localization, effectors, cargo, kinetics, and recent disease/physiology links; includes quantitative values and context-ID citations for traceability.*

Verification of target identity and domains
- The literature positions RAB15 as a human Rab-family small GTPase involved in endosomal sorting/recycling, consistent with UniProt P59190 (Rab family, P‑loop NTPase). No conflicting gene symbol usage was found in the cited human-focused literature, and organism context is Homo sapiens (Oct 2014, Experimental Cell Research; Nov 2011, Clinical Genetics) (bhuin2014rabproteinsthe pages 3-4, agola2011rabgtpasesas pages 2-3).

Limitations and open questions
- Specific GEFs/GAPs for RAB15 beyond modulatory roles (e.g., Mss4) are not definitively established in the retrieved sources; RIN-family GEFs are well known for Rab5 but not specifically shown for RAB15 here (agola2011rabgtpasesas pages 2-3, strick2005rab15effectorprotein pages 2-3).
- Interactions with APPL1, EHD/MICAL-L1, and RUFY proteins are central to recycling in general, but direct physical links to RAB15 are not demonstrated in the sources beyond REP15; therefore, their involvement should be viewed as pathway-contextual rather than RAB15-specific (Aug 2010, World J Biol Chem; https://doi.org/10.4331/wjbc.v1.i8.254) (rahajeng2010importantrelationshipsbetween pages 4-6).

Conclusions
- RAB15 is a human endosomal Rab GTPase that coordinates sorting at EEs/SEs and regulates ERC-derived recycling to the plasma membrane. Its best-characterized effector, REP15, specifically binds RAB15-GTP and restricts TfR recycling from the ERC without altering entry or rapid SE recycling, placing the RAB15–REP15 module at the slow, ERC branch of the recycling pathway. Quantitative imaging and kinetic assays substantiate these roles. Recent systems-oncology studies implicate RAB15 expression in prognostic signatures; however, direct, disease-causal roles and clinical utility require further validation in relevant models (Dec 2005, Mol Biol Cell; Nov 2011, Clinical Genetics; Oct 2014, Experimental Cell Research; Dec 2024, Frontiers in Immunology; Jul 2022, BMC Cancer) (strick2005rab15effectorprotein pages 4-6, strick2005rab15effectorprotein pages 6-8, agola2011rabgtpasesas pages 2-3, bhuin2014rabproteinsthe pages 3-4, wang2024anovelliquidliquid pages 13-16, kawatashimamura2022biomarkerdiscoveryfor pages 7-10).

References

1. (bhuin2014rabproteinsthe pages 3-4): Tanmay Bhuin and Jagat Kumar Roy. Rab proteins: the key regulators of intracellular vesicle transport. Experimental cell research, 328 1:1-19, Oct 2014. URL: https://doi.org/10.1016/j.yexcr.2014.07.027, doi:10.1016/j.yexcr.2014.07.027. This article has 339 citations and is from a peer-reviewed journal.

2. (bhuin2014rabproteinsthe pages 4-5): Tanmay Bhuin and Jagat Kumar Roy. Rab proteins: the key regulators of intracellular vesicle transport. Experimental cell research, 328 1:1-19, Oct 2014. URL: https://doi.org/10.1016/j.yexcr.2014.07.027, doi:10.1016/j.yexcr.2014.07.027. This article has 339 citations and is from a peer-reviewed journal.

3. (agola2011rabgtpasesas pages 2-3): J. Agola, Jim Pa, Heather H. Ward, Soumik Basuray, and A. Wandinger-Ness. Rab gtpases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clinical Genetics, 80:305-318, Oct 2011. URL: https://doi.org/10.1111/j.1399-0004.2011.01724.x, doi:10.1111/j.1399-0004.2011.01724.x. This article has 188 citations and is from a peer-reviewed journal.

4. (strick2005rab15effectorprotein pages 4-6): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

5. (strick2005rab15effectorprotein pages 6-8): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

6. (wang2024anovelliquidliquid pages 13-16): Shuo Wang, Sen Hou, Shan Jiang, Chao Wang, Peipei Zhang, Yingjiang Ye, and Zhidong Gao. A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer. Frontiers in Immunology, Dec 2024. URL: https://doi.org/10.3389/fimmu.2024.1514613, doi:10.3389/fimmu.2024.1514613. This article has 0 citations and is from a peer-reviewed journal.

7. (kawatashimamura2022biomarkerdiscoveryfor pages 7-10): Yumiko Kawata-Shimamura, Hidetaka Eguchi, Reika Kawabata-Iwakawa, Mitsuhiko Nakahira, Yasushi Okazaki, Tetsuya Yoda, Reidar Grénman, Masashi Sugasawa, and Masahiko Nishiyama. Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents. BMC Cancer, Jul 2022. URL: https://doi.org/10.1186/s12885-022-09853-1, doi:10.1186/s12885-022-09853-1. This article has 6 citations and is from a peer-reviewed journal.

8. (kitagishi2013rufyraband pages 7-9): Yasuko Kitagishi and Satoru Matsuda. Rufy, rab and rap family proteins involved in a regulation of cell polarity and membrane trafficking. International Journal of Molecular Sciences, 14:6487-6498, Mar 2013. URL: https://doi.org/10.3390/ijms14036487, doi:10.3390/ijms14036487. This article has 44 citations and is from a poor quality or predatory journal.

9. (strick2005rab15effectorprotein pages 2-3): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

10. (rahajeng2010importantrelationshipsbetween pages 4-6): J. Rahajeng, S. Giridharan, Bishuang Cai, Naava Naslavsky, and S. Caplan. Important relationships between rab and mical proteins in endocytic trafficking. World journal of biological chemistry, 1 8:254-64, Aug 2010. URL: https://doi.org/10.4331/wjbc.v1.i8.254, doi:10.4331/wjbc.v1.i8.254. This article has 39 citations.

11. (strick2005rab15effectorprotein pages 1-2): David J. Strick and Lisa A. Elferink. Rab15 effector protein: a novel protein for receptor recycling from the endocytic recycling compartment. Molecular biology of the cell, 16 12:5699-709, Dec 2005. URL: https://doi.org/10.1091/mbc.e05-03-0204, doi:10.1091/mbc.e05-03-0204. This article has 52 citations and is from a domain leading peer-reviewed journal.

## Citations

1. bhuin2014rabproteinsthe pages 3-4
2. agola2011rabgtpasesas pages 2-3
3. wang2024anovelliquidliquid pages 13-16
4. kawatashimamura2022biomarkerdiscoveryfor pages 7-10
5. kitagishi2013rufyraband pages 7-9
6. bhuin2014rabproteinsthe pages 4-5
7. rahajeng2010importantrelationshipsbetween pages 4-6
8. https://doi.org/10.1016/j.yexcr.2014.07.027
9. https://doi.org/10.1111/j.1399-0004.2011.01724.x
10. https://doi.org/10.1091/mbc.E05-03-0204
11. https://doi.org/10.3389/fimmu.2024.1514613
12. https://doi.org/10.1186/s12885-022-09853-1
13. https://doi.org/10.3390/ijms14036487
14. https://doi.org/10.1111/j.1399-0004.2011.01724.x;
15. https://doi.org/10.4331/wjbc.v1.i8.254;
16. https://doi.org/10.3389/fimmu.2024.1514613;
17. https://doi.org/10.4331/wjbc.v1.i8.254
18. https://doi.org/10.1016/j.yexcr.2014.07.027,
19. https://doi.org/10.1111/j.1399-0004.2011.01724.x,
20. https://doi.org/10.1091/mbc.e05-03-0204,
21. https://doi.org/10.3389/fimmu.2024.1514613,
22. https://doi.org/10.1186/s12885-022-09853-1,
23. https://doi.org/10.3390/ijms14036487,
24. https://doi.org/10.4331/wjbc.v1.i8.254,